- The influence of serotonin on the formation of clinical symptoms of functional gastrointestinal disorders in children
The influence of serotonin on the formation of clinical symptoms of functional gastrointestinal disorders in children
Modern Pediatrics. Ukraine. (2023). 6(134): 44-47. doi 10.15574/SP.2023.134.44
Belousova O. Yu.1, Urbonas Vaidotas 2, Kazarian L. V.1
1Kharkov National Medical University, Ukraine
2Vilnius University, Faculty of Medicine Institute of Clinical Medicine Clinic for Children’s Diseases
For citation: Belousova OYu, Urbonas Vaidotas, Kazarian LV. (2023). The influence of serotonin on the formation of clinical symptoms of functional gastrointestinal disorders in children. Modern Pediatrics. Ukraine. 6(134): 44-47. doi 10.15574/SP.2023.134.44.
Article received: Jun 29, 2023. Accepted for publication: Oct 06, 2023.
According to the Rome IV consensus (2016), functional gastrointestinal disorders (FGIDs) are disorders of the interaction between the gut and the brain. A crucial role in the realization of this mechanism is played by the key neurotransmitter serotonin.
Aim – to investigate the influence of serotonin on the formation of clinical symptoms in children with FGIDs.
Materials and methods. Under observation were 72 children aged 10-18 years with FGIDs. The Group I consisted of 30 children with combined functional dyspepsia (FD) and irritable bowel syndrome (IBS), the Group II included 42 children with FD. A control group of 20 healthy children was established. The diagnosis of FD and IBS was established based on the analysis of clinical symptoms according to the Rome IV criteria (2016). The severity of clinical symptoms was assessed using the Likert scale from 0 to 5 points. The study of serotonin content in whole blood was conducted using a fluorometric method after adsorption on carboxymethylcellulose.
Results. The intensity of abdominal pain and the severity of dyspeptic syndrome in children with combined FD and IBS is higher than in children with FD (p<0.01; p<0.05, respectively). The serotonin content in whole blood in children with FGIDs is lower than in healthy children (p<0.001). In children with combined FD and IBS, the serotonin content is lower than in children with FD (p<0.05). Reverse correlation links were found between serotonin content and the intensity of pain syndrome (r=-0.7), the severity of dyspeptic syndromes (r=-0.5), constipation (r=-0.7), and diarrhea (r=0.7).
Conclusions. The obtained research results indicate the influence of serotonin on the formation of clinical symptoms in children with FD and combined FD and IBS.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
Keywords: functional gastrointestinal disorders, functional dyspepsia, combined functional dyspepsia and irritable bowel syndrome, children, serotonin.
REFERENCES
1. Barnes NM, Ahern GP, Becamel C, Bockaert J et al. (2021, Jan). International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacological Reviews. 73 (1): 310-520. https://doi.org/10.1124/pr.118.015552; PMid:33370241 PMCid:PMC7770494
2. Cheung CK, Lee YY, Chan Y, Cheong PK, Law WT, Lee SF et al. (2013, Sep). Decreased Basal and postprandial plasma serotonin levels in patients with functional dyspepsia. Clin Gastroenterol Hepatol. 11 (9): 1125-1129. Epub 2013 Apr 13. https://doi.org/10.1016/j.cgh.2013.03.026; PMid:23591288
3. Drossman DA, Hasler WL. (2016). Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 150 (6): 1257-1261. https://doi.org/10.1053/j.gastro.2016.03.035; PMid:27147121
4. Drossman DA, Tack J. Ford AC, Szigethy E et al. (2018). Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut Brain Interaction): A Rome Foundation Working Team Report. Gastroenterology. 154: 1140-1171. https://doi.org/10.1053/j.gastro.2017.11.279; PMid:29274869
5. Ferrão BM, Chehter EZ. (2023). The importance of serotonin in the treatment of functional dyspepsia. Seven Editora: 51-66. URL: https://sevenpublicacoes.com.br/index.php/editora/article/view/1142. https://doi.org/10.56238/ciesaudesv1-006
6. Guzel T, Mirowska-Guzel D. (2022). The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy. Molecules. 27: 1680. https://doi.org/10.3390/molecules27051680; PMid:35268781 PMCid:PMC8911970
7. Kostyukovska LS. (1993). Improved method for determining serotonin levels in the blood in patients in clinical neurology. Ukrainian Journal of Psychoneurology. 1-2 (25): 12-16.
8. Mishchuk V, Grygoruk G. (2018). Serotonin Level and Lipid Metabolism Indices in Patients with Irritable Bowel Syndrome with Constipation Against the Background of Various Degrees of Obesity. Galician Medical Journal. 25: 2. https://doi.org/10.21802/gmj.2018.2.1
9. Poshehonova J, Makhmutov R, Shaban N. (2020). Some pathgenic aspects of functional dispepsia in children. Magyar Tudományos Journal. 38: 37-41.
10. Vahora IS, Tsouklidis N, Kumar R et al. (2020, Aug 19). How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome. Cureus. 12 (8): e9871. https://doi.org/10.7759/cureus.9871
11. Vernon-Roberts A, Alexander I, Day AS. (2021, Oct 29). Systematic Review of Pediatric Functional Gastrointestinal Disorders (Rome IV Criteria). J Clin Med. 10 (21): 5087. https://doi.org/10.3390/jcm10215087; PMid:34768604 PMCid:PMC8585107
12. Videlock EJ, Chang L. (2021, Sep). Latest Insights on the Pathogenesis of Irritable Bowel Syndrome. Gastroenterol Clin North Am. 50 (3): 505-522. https://doi.org/10.1016/j.gtc.2021.04.002; PMid:34304785
13. Xiao M, Ying J, Zhao Y, Zhao Y, Liu Y, Lu F. (2021, Jun 29). Developing a Scale for the Evaluation of People With Post-prandial Distress Syndrome. Front Public Health. 9: 695809. https://doi.org/10.3389/fpubh.2021.695809; PMid:34268292 PMCid:PMC8275927
14. Zhai L, Huang C, Ning Z, Zhang Y et al. (2022). Phenethylamine-producing gut bacteria induces diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis. bioRxiv. Preprint 2022.03.05.483096. https://doi.org/10.1101/2022.03.05.483096